USA flag logo/image

An Official Website of the United States Government

Quantifying proprioceptive acuity in individuals with motor disability

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
Program Year/Program:
2012 / SBIR
Agency Tracking Number:
R43NS074613
Solicitation Year:
2012
Solicitation Topic Code:
NINDS
Solicitation Number:
PA11-096
Small Business Information
AMES TECHNOLOGY, INC.
657 SW REGENCY PL PORTLAND, OR 97220-6060
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2012
Title: Quantifying proprioceptive acuity in individuals with motor disability
Agency: HHS
Contract: 1R43NS074613-01A1
Award Amount: $256,255.00
 

Abstract:

DESCRIPTION (provided by applicant): Volitional, coordinated movement depends on proprioception to the extent that a loss of proprioception can lead to a lifetime of dyscoordinated movement. Proprioception can be adversely affected by spinal cord injury(SCI), stroke, and traumatic brain injury (TBI). Given the influence of proprioception on normal movement and on movement disorders, the PI's laboratory has developed a novel approach to treat sensory and motor impairments in the limbs of persons with SCI,stroke, and TBI. This approach involves a robotic rehabilitation device that helps a patient move the affected limb while providing somatosensory stimulation. This approach is called AMES: Assisted Movement with Enhanced Sensation. Clinical studies have shown that AMES treatment reduces impairments, which can lead to a restoration of functional movement. The objective of the proposed research is to develop a proprioception assessment tool for the AMES robotic device, which will be used, in conjunction withexisting tests of motor impairment, to track the level of sensory impairment while a patient is treated with AMES. The hypothesis underlying this proposed study is that, in persons with somatosensory, as well as motor, impairments, recovery of somatosensation is a prerequisite to the recovery of motor function. The proposed research has 2 specific aims. The first aim is to develop software to implement a proprioception assessment tool on an existing AMES robotic device, to modify the hardware of the deviceso that the proprioceptive acuity of patients with severe motor disability can be quantified, and to bench-test the new software and hardware. The second aim is to evaluate, preliminarily, this clinical assessment tool on a small number of persons with chronic incomplete SCI and to compare the results from the proprioception assessment tool to other existing somatosensory tests currently in use, in the clinic. Test results from this proposed research will then form the preliminary data for a Phase 2 application to validate the proprioception assessment tool in a multicenter study involving a larger group of SCI participants. PUBLIC HEALTH RELEVANCE: This research addresses the need for an objective, quantitative assessment of proprioception that can be used, to evaluate the extent and type of proprioceptive loss in patients with motor deficits. With this proprioception assessment tool, clinicians using the AMES robotic device therapeutically may be better able to monitor the progressive loss or recovery of proprioceptive acuity in response to disease or to medical interventions, thereby guiding decisions about the treatment regimen to be used.

Principal Investigator:

Paul Cordo
503-970-6129
cordop@amesdevices.com

Business Contact:

Roger Weyel
503-704-1909
rweyel@amesdevices.com
Small Business Information at Submission:

AMES TECHNOLOGY, INC.
657 SW REGENCY PL PORTLAND, OR 97220-6060

EIN/Tax ID: 120153048
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No